{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:31:52Z","timestamp":1791973912385,"version":"4.4.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.iac.2014.01.002","type":"journal-article","created":{"date-parts":[[2014,3,15]],"date-time":"2014-03-15T16:30:32Z","timestamp":1394901032000},"page":"219-237","source":"Crossref","is-referenced-by-count":89,"title":["Functional Deregulation of KIT"],"prefix":"10.1016","volume":"34","author":[{"given":"Glenn","family":"Cruse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean D.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Olivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2014.01.002_bib1","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1002\/j.1460-2075.1987.tb02655.x","article-title":"Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand","volume":"6","author":"Yarden","year":"1987","journal-title":"EMBO J"},{"key":"10.1016\/j.iac.2014.01.002_bib2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/j.1460-2075.1988.tb02907.x","article-title":"Primary structure of c-kit: relationship with the CSF-1\/PDGF receptor kinase family\u2013oncogenic activation of v-kit involves deletion of extracellular domain and C terminus","volume":"7","author":"Qiu","year":"1988","journal-title":"EMBO J"},{"key":"10.1016\/j.iac.2014.01.002_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(90)90299-T","article-title":"The kit ligand: a cell surface molecule altered in steel mutant fibroblasts","volume":"63","author":"Flanagan","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.iac.2014.01.002_bib4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.V90.4.1345","article-title":"Stem cell factor and hematopoiesis","volume":"90","author":"Broudy","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib5","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.1073\/pnas.89.16.7350","article-title":"Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor","volume":"89","author":"Toksoz","year":"1992","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.iac.2014.01.002_bib6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejphar.2005.12.067","article-title":"Stem cell factor and its receptor c-Kit as targets for inflammatory diseases","volume":"533","author":"Reber","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.iac.2014.01.002_bib7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1182\/blood.V85.3.641.bloodjournal853641","article-title":"Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form","volume":"85","author":"Miyazawa","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib8","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1357-2725(99)00076-X","article-title":"The biology of stem cell factor and its receptor C-kit","volume":"31","author":"Ashman","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.iac.2014.01.002_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.174.1.63","article-title":"Expression and function of c-kit in hemopoietic progenitor cells","volume":"174","author":"Ogawa","year":"1991","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.iac.2014.01.002_bib10","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1182\/blood-2006-08-037770","article-title":"Steel factor responsiveness regulates the high self-renewal phenotype of fetal hematopoietic stem cells","volume":"109","author":"Bowie","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.iac.2006.05.004","article-title":"Molecular mechanisms of mast cell development","volume":"26","author":"Kitamura","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.iac.2014.01.002_bib12","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/bjp.2008.204","article-title":"Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders","volume":"154","author":"Jensen","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.iac.2014.01.002_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1634\/stemcells.2004-0117","article-title":"Normal and oncogenic forms of the receptor tyrosine kinase kit","volume":"23","author":"Lennartsson","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.iac.2014.01.002_bib14","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1357-2725(99)00078-3","article-title":"Early signaling pathways activated by c-Kit in hematopoietic cells","volume":"31","author":"Linnekin","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.iac.2014.01.002_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000236928","article-title":"Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor","volume":"107","author":"Galli","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2014.01.002_bib16","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1182\/blood.V100.13.4291","article-title":"Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis","volume":"100","author":"Oliveira","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nm1766","article-title":"Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma","volume":"14","author":"Krishnamoorthy","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.iac.2014.01.002_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.186.2.313","article-title":"Human peripheral blood eosinophils express a functional c-kit receptor for stem cell factor that stimulates very late antigen 4 (VLA-4)-mediated cell adhesion to fibronectin and vascular cell adhesion molecule 1 (VCAM-1)","volume":"186","author":"Yuan","year":"1997","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.iac.2014.01.002_bib19","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jaci.2005.06.008","article-title":"Stem cell factor stimulates the chemotaxis, integrin upregulation, and survival of human basophils","volume":"116","author":"Heinemann","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2014.01.002_bib20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/373347a0","article-title":"W\/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity","volume":"373","author":"Huizinga","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.iac.2014.01.002_bib21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1365-2222.2004.01975.x","article-title":"The expression of stem cell factor and c-kit receptor in human asthmatic airways","volume":"34","author":"Al-Muhsen","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2014.01.002_bib22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jss.2004.01.005","article-title":"Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathway","volume":"120","author":"Hollenbeck","year":"2004","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.iac.2014.01.002_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0165-3806(94)00205-E","article-title":"Characterization of c-kit-positive neurons in the dorsal root ganglion of mouse","volume":"85","author":"Hirata","year":"1995","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.iac.2014.01.002_bib24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.it.2012.09.008","article-title":"New models for analyzing mast cell functions in\u00a0vivo","volume":"33","author":"Reber","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.iac.2014.01.002_bib25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1346-8138.2012.01583.x","article-title":"Piebaldism","volume":"40","author":"Oiso","year":"2013","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.iac.2014.01.002_bib26","first-page":"1709","article-title":"Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene","volume":"53","author":"Sekido","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.iac.2014.01.002_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1200\/JCO.2005.02.093","article-title":"KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors","volume":"23","author":"Sihto","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.iac.2014.01.002_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3892\/ol.2012.679","article-title":"Expression and mutation of the c-kit gene and correlation with prognosis of small cell lung cancer","volume":"4","author":"Lu","year":"2012","journal-title":"Oncol Lett"},{"key":"10.1016\/j.iac.2014.01.002_bib29","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.ejca.2013.04.005","article-title":"Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13","volume":"49","author":"Bachet","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.iac.2014.01.002_bib30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.iac.2014.01.002_bib31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/10428199909058472","article-title":"Effects of mutant c-Kit in early myeloid cells","volume":"34","author":"Ashman","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.iac.2014.01.002_bib32","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1152\/physrev.00046.2011","article-title":"Stem cell factor receptor\/c-Kit: from basic science to clinical implications","volume":"92","author":"Lennartsson","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1016\/j.iac.2014.01.002_bib33","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","article-title":"Mast cells and mastocytosis","volume":"112","author":"Metcalfe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4251\/wjgo.v5.i6.102","article-title":"A\u00a0gist of gastrointestinal stromal tumors: a review","volume":"5","author":"Rammohan","year":"2013","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.iac.2014.01.002_bib35","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.iac.2014.01.002_bib36","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000315946","article-title":"Mastocytosis","volume":"95","author":"Brockow","year":"2010","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.iac.2014.01.002_bib38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1517\/13543784.2012.679341","article-title":"A\u00a0potential role for nilotinib in KIT-mutated melanoma","volume":"21","author":"Tran","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.iac.2014.01.002_bib39","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/sj.jid.5700125","article-title":"Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes","volume":"126","author":"Alexeev","year":"2006","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.iac.2014.01.002_bib40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11899-009-0011-8","article-title":"Clinical implications of c-Kit mutations in acute myelogenous leukemia","volume":"4","author":"Malaise","year":"2009","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.iac.2014.01.002_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/13543784.2013.740010","article-title":"Therapeutic targeting of c-KIT in cancer","volume":"22","author":"Ashman","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.iac.2014.01.002_bib42","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/j.seminoncol.2011.01.010","article-title":"Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: are we there yet?","volume":"38","author":"Odenike","year":"2011","journal-title":"Semin Oncol"},{"key":"10.1016\/j.iac.2014.01.002_bib43","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.4049\/jimmunol.146.5.1410","article-title":"Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells","volume":"146","author":"Kirshenbaum","year":"1991","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.iac.2014.01.002_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.immuni.2012.07.003","article-title":"Developmental origin and functional specialization of mast cell subsets","volume":"37","author":"Gurish","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.iac.2014.01.002_bib45","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jaci.2006.04.015","article-title":"Molecular regulation of mast cell activation","volume":"117","author":"Rivera","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2014.01.002_bib46","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nri1782","article-title":"Integrated signalling pathways for mast-cell activation","volume":"6","author":"Gilfillan","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.iac.2014.01.002_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/ejh.12043","article-title":"Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression","volume":"90","author":"Verstovsek","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.iac.2014.01.002_bib48","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood.V87.8.3117.bloodjournal8783117","article-title":"A\u00a0point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells","volume":"87","author":"Piao","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000237541","article-title":"c-kit mutation in a population of patients with mastocytosis","volume":"113","author":"Nagata","year":"1997","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2014.01.002_bib50","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng0396-312","article-title":"Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm","volume":"12","author":"Longley","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.iac.2014.01.002_bib51","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1523-1747.1998.00414.x","article-title":"Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior","volume":"111","author":"Buttner","year":"1998","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.iac.2014.01.002_bib52","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","article-title":"Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations","volume":"130","author":"Bodemer","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.iac.2014.01.002_bib53","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3324\/haematol.2010.031690","article-title":"Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis","volume":"96","author":"Wilson","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.iac.2014.01.002_bib54","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/00365520701245744","article-title":"Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder","volume":"42","author":"Molderings","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.iac.2014.01.002_bib55","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.exphem.2013.05.005","article-title":"KIT GNNK splice variants: expression in systemic mastocytosis and influence on the activating potential of the D816V mutation in mast cells","volume":"41","author":"Chan","year":"2013","journal-title":"Exp Hematol"},{"key":"10.1016\/j.iac.2014.01.002_bib56","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2014.01.002_bib57","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cell.2007.05.055","article-title":"Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor","volume":"130","author":"Yuzawa","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.iac.2014.01.002_bib58","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.1074\/jbc.272.10.6311","article-title":"Kit receptor dimerization is driven by bivalent binding of stem cell factor","volume":"272","author":"Lemmon","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iac.2014.01.002_bib59","doi-asserted-by":"crossref","first-page":"31655","DOI":"10.1074\/jbc.M403319200","article-title":"Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase","volume":"279","author":"Mol","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iac.2014.01.002_bib60","doi-asserted-by":"crossref","first-page":"31461","DOI":"10.1074\/jbc.C300186200","article-title":"Structure of a c-kit product complex reveals the basis for kinase transactivation","volume":"278","author":"Mol","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iac.2014.01.002_bib61","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1002\/j.1460-2075.1991.tb04989.x","article-title":"Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis","volume":"10","author":"Blume-Jensen","year":"1991","journal-title":"EMBO J"},{"key":"10.1016\/j.iac.2014.01.002_bib62","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0092-8674(03)01077-8","article-title":"Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems","volume":"116","author":"Pawson","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.iac.2014.01.002_bib63","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s00018-004-4189-6","article-title":"Signal transduction via the stem cell factor receptor\/c-Kit","volume":"61","author":"Ronnstrand","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.iac.2014.01.002_bib64","doi-asserted-by":"crossref","first-page":"27450","DOI":"10.1074\/jbc.272.43.27450","article-title":"Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells","volume":"272","author":"Linnekin","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iac.2014.01.002_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/excr.1999.4732","article-title":"Src family tyrosine kinases and growth factor signaling","volume":"254","author":"Abram","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.iac.2014.01.002_bib66","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood.V98.2.343","article-title":"Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells","volume":"98","author":"O'Laughlin-Bunner","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib67","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1128\/MCB.21.24.8318-8328.2001","article-title":"Structure-function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after Fcepsilon receptor I aggregation","volume":"21","author":"Kovarova","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.iac.2014.01.002_bib68","first-page":"1979","article-title":"Signaling via Src family kinases is required for normal internalization of the receptor c-Kit","volume":"94","author":"Broudy","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib69","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood-2006-05-020925","article-title":"Lipid rafts are required for Kit survival and proliferation signals","volume":"110","author":"Jahn","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib70","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cellsig.2006.12.003","article-title":"Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling","volume":"19","author":"Arcaro","year":"2007","journal-title":"Cell Signal"},{"key":"10.1016\/j.iac.2014.01.002_bib71","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1242\/jcs.00609","article-title":"The phosphoinositide (PI) 3-kinase family","volume":"116","author":"Foster","year":"2003","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.iac.2014.01.002_bib72","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ni768","article-title":"Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice","volume":"3","author":"Fukao","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.iac.2014.01.002_bib73","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1182\/blood-2002-08-2521","article-title":"Genetic evidence for convergence of c-Kit- and alpha4 integrin-mediated signals on class IA PI-3kinase and the Rac pathway in regulating integrin-directed migration in mast cells","volume":"101","author":"Tan","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib74","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.8493579","article-title":"Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2","volume":"260","author":"Chardin","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.iac.2014.01.002_bib75","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","article-title":"ERK1\/2 MAP kinases: structure, function, and regulation","volume":"66","author":"Roskoski","year":"2012","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.iac.2014.01.002_bib76","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2009.01.022","article-title":"Targeting the RAF-MEK-ERK pathway in cancer therapy","volume":"283","author":"Montagut","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.iac.2014.01.002_bib77","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V85.3.790.bloodjournal853790","article-title":"Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines","volume":"85","author":"Kitayama","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib78","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jlb.67.2.135","article-title":"c-Kit and c-kit mutations in mastocytosis and other hematological diseases","volume":"67","author":"Boissan","year":"2000","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.iac.2014.01.002_bib79","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.leukres.2011.05.006","article-title":"Tyrosine kinase inhibitors in the treatment of systemic mastocytosis","volume":"35","author":"Ustun","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.iac.2014.01.002_bib80","doi-asserted-by":"crossref","first-page":"e1002068","DOI":"10.1371\/journal.pcbi.1002068","article-title":"Mutation D816V alters the internal structure and dynamics of c-KIT receptor cytoplasmic region: implications for dimerization and activation mechanisms","volume":"7","author":"Laine","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.iac.2014.01.002_bib81","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1182\/blood-2004-06-2068","article-title":"KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor","volume":"105","author":"Kohl","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib82","doi-asserted-by":"crossref","first-page":"e1002661","DOI":"10.1371\/journal.pcbi.1002661","article-title":"Allosteric communication across the native and mutated KIT receptor tyrosine kinase","volume":"8","author":"Laine","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.iac.2014.01.002_bib83","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/prot.21928","article-title":"Detailed conformational dynamics of juxtamembrane region and activation loop in c-Kit kinase activation process","volume":"72","author":"Zou","year":"2008","journal-title":"Proteins"},{"key":"10.1016\/j.iac.2014.01.002_bib84","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/blood.V93.4.1319","article-title":"Activating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-association not at the ligand-induced dimerization site","volume":"93","author":"Tsujimura","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib85","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1021\/jm050231m","article-title":"Molecular modeling of wild-type and D816V c-Kit inhibition based on ATP-competitive binding of ellipticine derivatives to tyrosine kinases","volume":"48","author":"Vendome","year":"2005","journal-title":"J\u00a0Med Chem"},{"issue":"Pt 1","key":"10.1016\/j.iac.2014.01.002_bib86","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1042\/0264-6021:3380131","article-title":"A\u00a0transforming mutation enhances the activity of the c-Kit soluble tyrosine kinase domain","volume":"338","author":"Lam","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.iac.2014.01.002_bib87","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1038\/sj.onc.1206587","article-title":"Signal transduction by several KIT juxtamembrane domain mutations","volume":"22","author":"Casteran","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.iac.2014.01.002_bib88","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/35077225","article-title":"Oncogenic kinase signalling","volume":"411","author":"Blume-Jensen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.iac.2014.01.002_bib89","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood.V98.5.1365","article-title":"Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant","volume":"98","author":"Chian","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib90","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1182\/blood.V97.11.3559","article-title":"Signal transducer and activator of transcription 3 activation is required for Asp(816) mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells","volume":"97","author":"Ning","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib91","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood-2009-06-226027","article-title":"Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations","volume":"116","author":"Yang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib92","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1128\/MCB.18.4.2089","article-title":"SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain","volume":"18","author":"Kozlowski","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.iac.2014.01.002_bib93","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1007\/s00018-003-3010-2","article-title":"The odd couple: signal transduction and endocytosis","volume":"60","author":"Teis","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.iac.2014.01.002_bib94","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrm2748","article-title":"Endocytosis and signalling: intertwining molecular networks","volume":"10","author":"Sorkin","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.iac.2014.01.002_bib95","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1242\/jcs.115.2.303","article-title":"Active EGF receptors have limited access to PtdIns(4,5)P(2) in endosomes: implications for phospholipase C and PI 3-kinase signaling","volume":"115","author":"Haugh","year":"2002","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.iac.2014.01.002_bib96","doi-asserted-by":"crossref","first-page":"35301","DOI":"10.1074\/jbc.274.50.35301","article-title":"Dynamin is required for the activation of mitogen-activated protein (MAP) kinase by MAP kinase kinase","volume":"274","author":"Kranenburg","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iac.2014.01.002_bib97","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1126\/science.274.5295.2086","article-title":"Control of EGF receptor signaling by clathrin-mediated endocytosis","volume":"274","author":"Vieira","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.iac.2014.01.002_bib98","doi-asserted-by":"crossref","first-page":"e41354","DOI":"10.1371\/journal.pone.0041354","article-title":"Differential regulation of transcription factors by location-specific EGF receptor signaling via a spatio-temporal interplay of ERK activation","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.iac.2014.01.002_bib99","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.cellsig.2009.07.007","article-title":"F-BAR-containing adaptor CIP4 localizes to early endosomes and regulates epidermal growth factor receptor trafficking and downregulation","volume":"21","author":"Hu","year":"2009","journal-title":"Cell Signal"},{"key":"10.1016\/j.iac.2014.01.002_bib100","doi-asserted-by":"crossref","first-page":"ra21","DOI":"10.1126\/scisignal.2002351","article-title":"Regulation of the EGF transcriptional response by endocytic sorting","volume":"5","author":"Brankatschk","year":"2012","journal-title":"Sci Signal"},{"key":"10.1016\/j.iac.2014.01.002_bib101","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1091\/mbc.12.6.1897","article-title":"Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking","volume":"12","author":"Burke","year":"2001","journal-title":"Mol Biol Cell"},{"issue":"Pt 2","key":"10.1016\/j.iac.2014.01.002_bib102","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/0264-6021:3510289","article-title":"Meaningful relationships: the regulation of the Ras\/Raf\/MEK\/ERK pathway by protein interactions","volume":"351","author":"Kolch","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.iac.2014.01.002_bib103","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1534-5807(02)00364-7","article-title":"Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction","volume":"3","author":"Teis","year":"2002","journal-title":"Dev Cell"},{"key":"10.1016\/j.iac.2014.01.002_bib104","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1091\/mbc.E07-02-0098","article-title":"Late endosomal traffic of the epidermal growth factor receptor ensures spatial and temporal fidelity of mitogen-activated protein kinase signaling","volume":"18","author":"Taub","year":"2007","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.iac.2014.01.002_bib105","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1083\/jcb.200607025","article-title":"p14-MP1-MEK1 signaling regulates endosomal traffic and cellular proliferation during tissue homeostasis","volume":"175","author":"Teis","year":"2006","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.iac.2014.01.002_bib106","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood-2010-04-279752","article-title":"New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinases","volume":"116","author":"Toffalini","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib107","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/MCB.01153-06","article-title":"Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling","volume":"27","author":"Xiang","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.iac.2014.01.002_bib108","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1172\/JCI63711","article-title":"Smap1 deficiency perturbs receptor trafficking and predisposes mice to myelodysplasia","volume":"123","author":"Kon","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.iac.2014.01.002_bib109","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.biochem.75.103004.142657","article-title":"Tyrphostins and other tyrosine kinase inhibitors","volume":"75","author":"Levitzki","year":"2006","journal-title":"Annu Rev Biochem"},{"issue":"6","key":"10.1016\/j.iac.2014.01.002_bib110","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.clml.2013.05.012","article-title":"A\u00a0critical review of trials of first-line BCR-ABL inhibitor treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase","volume":"13","author":"Jabbour","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.iac.2014.01.002_bib111","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jaad.2013.07.025","article-title":"Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia","volume":"69","author":"Delgado","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.iac.2014.01.002_bib112","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3816\/CLML.2010.n.026","article-title":"First-line therapy for chronic myeloid leukemia: new horizons and an update","volume":"10","author":"Saglio","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.iac.2014.01.002_bib113","first-page":"316","article-title":"KIT inhibitor midostaurin exhibits a high rate of clinically meaningful and durable responses in advanced systemic mastocytosis: report of a fully accrued phase II trial","volume":"116","author":"Gotlib","year":"2010","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"10.1016\/j.iac.2014.01.002_bib114","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/leu.2012.218","article-title":"Targeting the KIT activating switch control pocket: a novel mechanism to inhibit neoplastic mast cell proliferation and mast cell activation","volume":"27","author":"Bai","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.iac.2014.01.002_bib115","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.jaci.2012.12.674","article-title":"Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis","volume":"131","author":"Teodosio","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2014.01.002_bib116","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1398-9995.2010.02477.x","article-title":"Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis","volume":"66","author":"Niedoszytko","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2014.01.002_bib117","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1158\/1535-7163.MCT-09-1186","article-title":"Metformin in cancer therapy: a new perspective for an old antidiabetic drug?","volume":"9","author":"Ben Sahra","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.iac.2014.01.002_bib118","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature11862","article-title":"Metabolism of inflammation limited by AMPK and pseudo-starvation","volume":"493","author":"O'Neill","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.iac.2014.01.002_bib119","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chembiol.2011.12.008","article-title":"RNA-based therapeutics: current progress and future prospects","volume":"19","author":"Burnett","year":"2012","journal-title":"Chem Biol"},{"key":"10.1016\/j.iac.2014.01.002_bib120","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nbt1392","article-title":"MicroRNAs accurately identify cancer tissue origin","volume":"26","author":"Rosenfeld","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.iac.2014.01.002_bib121","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.3390\/cancers3043957","article-title":"Emerging evidence for MicroRNAs as regulators of cancer stem cells","volume":"3","author":"Sethi","year":"2011","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.iac.2014.01.002_bib122","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4049\/jimmunol.182.1.433","article-title":"MicroRNA-221-222 regulate the cell cycle in mast cells","volume":"182","author":"Mayoral","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.iac.2014.01.002_bib123","doi-asserted-by":"crossref","first-page":"e26133","DOI":"10.1371\/journal.pone.0026133","article-title":"MiR-221 influences effector functions and actin cytoskeleton in mast cells","volume":"6","author":"Mayoral","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.iac.2014.01.002_bib124","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1182\/blood-2010-07-293548","article-title":"KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation","volume":"117","author":"Lee","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.002_bib125","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00005-010-0086-x","article-title":"Human mast cells and mastocytosis: harnessing microRNA expression as a new approach to therapy?","volume":"58","author":"Deho","year":"2010","journal-title":"Arch Immunol Ther Exp (Warsz)"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856114000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856114000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T06:27:33Z","timestamp":1689056853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856114000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":125,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0889856114000034"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2014.01.002","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}